InforSense 1.9 to Boost Genetic Research for Canadian Scientists
InforSense Ltd., the leading provider of Open Discovery Workflow informatics platforms, announced a multi-user multi-year license agreement with The Centre for Applied Genomics (TCAG) Microarray Facility at The Hospital for Sick Children in Toronto, Canada. The InforSense enterprise Knowledge Discovery Environment will provide a powerful software environment for the advanced analysis of Affymetrix GeneChip ™ data.
Via the core facility at TGAG, researchers can now access, analyze and interpret genomic data within the single integrated workflow-centric environment provided by InforSense 1.9. TCAG is an advanced infrastructure involved in innovative genetics and genomics research, including the isolation and characterization of disease genes of significant medical and therapeutic interest. The Microarray Facility is one of seven core facilities at TCAG that provide services accessible to all Canadian researchers.
Commenting on the agreement, Prof. Yike Guo, CEO of InforSense said: “We are extremely pleased to be able to support genomics research at the renowned Hospital for Sick Children, and to expand our existing user base within Canada. InforSense offers a unique and flexible environment that can support the innovative analysis approaches employed by users of The Centre for Applied Genomics.”
“The InforSense platform is comprehensive and flexible,” added Dr. Chao Lu, Manager & Analyst, TCAG Microarray Facility. “We find the approach of Open Discovery Workflows to be very intuitive and powerful, and the enterprise system promotes collaboration.
About InforSense
InforSense develops and mark ets next-generation discovery informatics platforms for individual researchers, cross-function teams and discovery enterprises based on its unique Open Discovery Workflow™ technology. Using InforSense technology, individuals and organizations can exploit diverse information and software systems to create, integrate, manage and deliver valuable discovery knowledge and intellectual property within a single, integrated informatics environment. InforSense’s unique value is based on the horizontal nature of its system enabling researchers to use the data they need, in whatever format, to drive their decision-making throughout the entire drug discovery research process from target discovery to drug development.
InforSense customers include major pharmaceutical and biotechnology companies, as well as academic research institutions worldwide.
For further information on InforSense products and solutions, visit www.inforsense.com .
About The Centre for Applied Genomics
Located at The Hospital for Sick Children in downtown Toronto, The Centre for Applied Genomics (TCAG) is the major component of the Ontario Genomics Institute and Genome Canada Genome Resource Platform and directly supports a staff of over 60 scientists, computational biologists, and technicians – providing services accessible to all Canadian researchers. See http://www.tcag.ca .
